1-6 of 6
Sylvie Lafaye de Micheaux
Close
Sort by
Journal Articles

Phase I/II Study of IPH1101, γσ T Cell Agonist, Combined with Rituximab, in Low Grade Follicular Lymphoma Patients.

Guy Laurent, MD, PhD, Sylvie Lafaye de Micheaux, MD, Philippe Solal-Celigny, MD, Pierre Soubeyran, MD, PhD, Vincent Delwail, Hervé Ghesquières, MD, Catherine Thieblemont, MD, Eric Jourdan, MD, PhD, Lucile Beautier, Fabien Audibert, Patrick Squiban, MD, Helene Sicard, PhD, Jean-Francois Rossi, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 1649.
https://doi.org/10.1182/blood.V114.22.1649.1649
Published: 2009
Journal Articles

In Follicular Lymphoma (FL), γδt-Lymphocytes (γδT) Are Present and Expandable from Peripheral Blood and Rare in Tumour Lymph Nodes, Mostly in Peri-Follicular Areas.

Mounia Braza, Therese Rousset, Majda Saifi, Guillaume Cartron, Sylvie Lafaye de Micheaux, Helene Sicard, Patrick Squiban, Valérie Costes, Jean-Francois Rossi
Journal: Blood
Blood (2008) 112 (11): 1773.
https://doi.org/10.1182/blood.V112.11.1773.1773
Published: 2008
Journal Articles

Cognitive Study of Reactivity to IPH1101 of Peripheral γδ T Lymphocytes from Chronic Myeloid Leukemia, Multiple Myeloma and Follicular Lymphoma Patients.

Helene Sicard, PhD, Jean-Francois Rossi, MD, PhD, Philippe Rousselot, MD, Alexis Collette, Christine Paiva, Sophie Ingoure, Sylvie Lafaye de Micheaux, MD
Journal: Blood
Blood (2008) 112 (11): 1530.
https://doi.org/10.1182/blood.V112.11.1530.1530
Published: 2008
Journal Articles

A Phase I/II Study of IPH1101 (BrHPP), Specific Agonist of Vã9Vä2 T Lymphocytes, in Combination with Rituximab Re-Treatment in Patients with Follicular Lymphoma. Interim Phase I Data.

Guy Laurent, MD, PhD, Jean François Rossi, MD, PhD, Eric W Van Den Neste, MD, PhD, Fabien Audibert, Hervé Ghesquières, MD, Steven Le Gouill, MD, PhD, Pierre Feugier, MD, Helene Sicard, PhD, Sophie Ingoure, Elodie Soule, Sylvie Lafaye de Micheaux, MD
Journal: Blood
Blood (2008) 112 (11): 1002.
https://doi.org/10.1182/blood.V112.11.1002.1002
Published: 2008
Journal Articles

Phase I Study of IPH1101 (with Low Dose of IL-2) in Patient with B-NHL

Jean François Rossi, MD, PhD, Valerie Rouillé, Sylvie Lafaye de Micheaux, MD, Hélène Sicard, PhD, Olivier Pétricoul, PhD, Lucile Beautier, Christine d’Arnoux, MD, Volker Kunzmann, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 5011.
https://doi.org/10.1182/blood.V112.11.5011.5011
Published: 2008
Journal Articles

Enhancing Lysis of B Cell Lymphoma by Innovative γδ T Cell Immunotherapies Using Agonist IPH1101 (Phosphostim, BrHPP).

Jean-Francois Rossi, PhD, MD, Julie Gertner, Helene Sicard, PhD, Guy Laurent PhD, MD, Sylvie Lafaye de Micheaux, MD, Jerome Tiollier, PhD, Jean-Jacques Fournie, PhD, Patrick Squiban, MD, Volker Kunzmann PhD, MD
Journal: Blood
Blood (2006) 108 (11): 5201.
https://doi.org/10.1182/blood.V108.11.5201.5201
Published: 2006